Amy L. Roe

3.7k total citations · 1 hit paper
41 papers, 1.8k citations indexed

About

Amy L. Roe is a scholar working on Pharmacology, Complementary and alternative medicine and Molecular Biology. According to data from OpenAlex, Amy L. Roe has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 11 papers in Complementary and alternative medicine and 10 papers in Molecular Biology. Recurrent topics in Amy L. Roe's work include Pharmacogenetics and Drug Metabolism (10 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Complementary and Alternative Medicine Studies (8 papers). Amy L. Roe is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Complementary and Alternative Medicine Studies (8 papers). Amy L. Roe collaborates with scholars based in United States, United Kingdom and Germany. Amy L. Roe's co-authors include Daniel W. Nebert, Timothy P. Dalton, Willy A. Solis, Matthew Z. Dieter, Yi Yang, Hellen Oketch‐Rabah, Greg G. Oakley, Eula Bingham, Joseph M. Betz and Ángela I. Calderón and has published in prestigious journals such as The Science of The Total Environment, Journal of Agricultural and Food Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Amy L. Roe

37 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis

2000 813 citations Daniel W. Nebert, Amy L. Roe et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy L. Roe United States	18	592	562	326	308	164	41	1.8k
Calivarathan Latchoumycandane India	27	604 1.0×	526 0.9×	255 0.8×	302 1.0×	276 1.7×	42	1.9k
Laurence Gamet‐Payrastre France	21	811 1.4×	304 0.5×	267 0.8×	138 0.4×	555 3.4×	41	2.1k
Chikako Uneyama Japan	25	761 1.3×	540 1.0×	224 0.7×	97 0.3×	142 0.9×	84	1.9k
Greg Cosma United States	20	872 1.5×	334 0.6×	397 1.2×	302 1.0×	127 0.8×	38	1.8k
Walter Meinl Germany	29	1.1k 1.8×	462 0.8×	608 1.9×	760 2.5×	157 1.0×	64	2.5k
Julian E.A. Leakey United States	25	615 1.0×	399 0.7×	271 0.8×	462 1.5×	150 0.9×	74	2.4k
Solomon E. Owumi Nigeria	27	415 0.7×	277 0.5×	159 0.5×	245 0.8×	550 3.4×	104	1.8k
Guillermo Elizondo Mexico	27	693 1.2×	369 0.7×	305 0.9×	280 0.9×	117 0.7×	68	1.9k
Pier Giovanni Gervasi Italy	27	513 0.9×	397 0.7×	293 0.9×	719 2.3×	152 0.9×	83	1.8k
Hennicke Kamp Germany	25	897 1.5×	363 0.6×	217 0.7×	223 0.7×	281 1.7×	71	1.8k

Countries citing papers authored by Amy L. Roe

Since Specialization

Citations

This map shows the geographic impact of Amy L. Roe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy L. Roe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy L. Roe more than expected).

Fields of papers citing papers by Amy L. Roe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy L. Roe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy L. Roe. The network helps show where Amy L. Roe may publish in the future.

Co-authorship network of co-authors of Amy L. Roe

This figure shows the co-authorship network connecting the top 25 collaborators of Amy L. Roe. A scholar is included among the top collaborators of Amy L. Roe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy L. Roe. Amy L. Roe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chikowe, Ibrahim, Nozgechi Phiri, Malango Msukwa, et al.. (2025). An exploratory evaluation of the interaction risk between herbal products and pharmaceutical medicines used concurrently for disease management in Blantyre, Malawi. Pharmaceutical Biology. 63(1). 877–895.

Liu, Yitong, et al.. (2025). Integration of computational models to predict botanical phytochemical constituent clearance routes by the Extended Clearance Classification System (ECCS). Toxicology and Applied Pharmacology. 500. 117385–117385.

Koturbash, Igor, Constance A. Mitchell, Stephen Ferguson, et al.. (2024). Botanical-induced toxicity: Liver injury and botanical-drug interactions. A report on a society of Toxicology Annual Meeting symposium. Regulatory Toxicology and Pharmacology. 153. 105708–105708. 3 indexed citations

Grehan, Keith, Mark Hassall, Guido C. Paesen, et al.. (2023). VelcroVax: a “Bolt-On” Vaccine Platform for Glycoprotein Display. mSphere. 8(1). e0056822–e0056822. 3 indexed citations

Roe, Amy L., James T. Heimbach, Emily A. Madden, et al.. (2022). Considerations for determining safety of probiotics: A USP perspective. Regulatory Toxicology and Pharmacology. 136. 105266–105266. 53 indexed citations

Roe, Amy L. & Arvind Venkataraman. (2021). The Safety and Efficacy of Botanicals with Nootropic Effects. Current Neuropharmacology. 19(9). 1442–1467. 12 indexed citations

Gaston, Tyler E., Donna L. Mendrick, Mary F. Paine, Amy L. Roe, & Catherine K. Yeung. (2020). “Natural” is not synonymous with “Safe”: Toxicity of natural products alone and in combination with pharmaceutical agents. Regulatory Toxicology and Pharmacology. 113. 104642–104642. 59 indexed citations

Roe, Amy L., et al.. (2019). The Botanical Safety Consortium. 5(1). 4–9.

Roe, Amy L., Rachel Wilcox, Lijuan Li, et al.. (2019). An Evaluation of Potential Inhibition of CYP3A4/5 and CYP2C9 Enzymatic Activity by Boswellia serrata Extract. 5(1). 34–46. 8 indexed citations

10.

Oketch‐Rabah, Hellen, et al.. (2019). Safety of Guarana Seed as a Dietary Ingredient: A Review. Journal of Agricultural and Food Chemistry. 67(41). 11281–11287. 18 indexed citations

11.

Desprez, Bertrand, Detlef Keller, Martina Klarić, et al.. (2018). A strategy for systemic toxicity assessment based on non-animal approaches: The Cosmetics Europe Long Range Science Strategy programme. Toxicology in Vitro. 50. 137–146. 42 indexed citations

12.

Jackson, Jonathan P., et al.. (2017). Prediction of Clinically Relevant Herb-Drug Clearance Interactions Using Sandwich-Cultured Human Hepatocytes: Schisandra spp. Case Study. Drug Metabolism and Disposition. 45(9). 1019–1026. 17 indexed citations

13.

Brouwer, Kenneth R., Stephen Ferguson, Yurong Lai, et al.. (2016). The Importance of In Vitro Liver Models: Experts Discuss Whole-Cell Systems, Transporter Function, and the Best Models for Future In Vitro Testing. 2(1). 1–7. 4 indexed citations

14.

Roe, Amy L., Mary F. Paine, Bill J. Gurley, et al.. (2016). Assessing Natural Product–Drug Interactions: An End-to-End Safety Framework. Regulatory Toxicology and Pharmacology. 76. 1–6. 28 indexed citations

15.

Oketch‐Rabah, Hellen, Amy L. Roe, Bill J. Gurley, James C. Griffiths, & Gabriel I. Giancaspro. (2016). The Importance of Quality Specifications in Safety Assessments of Amino Acids: The Cases of L-Tryptophan and L-Citrulline. Journal of Nutrition. 146(12). 2643S–2651S. 14 indexed citations

16.

Cowan‐Ellsberry, Christina, Scott D. Dyer, Susan Erhardt, et al.. (2007). Approach for extrapolating in vitro metabolism data to refine bioconcentration factor estimates. Chemosphere. 70(10). 1804–1817. 95 indexed citations

17.

Nebert, Daniel W., et al.. (2002). NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: A HuGE review. Genetics in Medicine. 4(2). 62–70. 150 indexed citations

18.

Roe, Amy L., Graham Warren, Guoqiang Hou, et al.. (1998). The Effect of High Dose Endotoxin on CYP3A2 Expression in the Rat. Pharmaceutical Research. 15(10). 1603–1608. 21 indexed citations

19.

Roe, Amy L., Robert A. Blouin, & Georgette Howard. (1996). In VivoPhenobarbital Treatment Increases Protein Binding to a Putative AP-1 Site in the CYP2B2 Promoter. Biochemical and Biophysical Research Communications. 228(1). 110–114. 14 indexed citations

20.

Neft, Robin E., et al.. (1992). Nitrobenzo[a]pyrene‐induced DNA amplification in SV40‐transformed chinese hamster embryo cells. Environmental and Molecular Mutagenesis. 19(2). 156–160.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact